We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+1.31%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$501B
AUM Growth
+$10.7B
Cap. Flow
+$11.6B
Cap. Flow %
2.32%
Top 10 Hldgs %
20.34%
Holding
7,459
New
484
Increased
3,145
Reduced
2,823
Closed
402

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.82B
2
V icon
Visa
V
+$890M
3
FTV icon
Fortive
FTV
+$739M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$457M
5
TSM icon
TSMC
TSM
+$392M

Sector Composition

Rank Sector Weight
1 Financials 18.21%
2 Technology 17.8%
3 Industrials 7.2%
4 Consumer Discretionary 7%
5 Healthcare 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHOC icon
5626
Strive US Semiconductor ETF
SHOC
$244M
$48K ﹤0.01%
1,036
-5,505
-84% -$257K
STXG icon
5627
Strive 1000 Growth ETF
STXG
$154M
$48K ﹤0.01%
1,117
TBPH icon
5628
Theravance Biopharma
TBPH
$881M
$48K ﹤0.01%
5,082
+1,334
+36% +$12.1K
XERS icon
5629
Xeris Biopharma Holdings
XERS
$1.57B
$48K ﹤0.01%
14,100
-16,160
-53% -$52K
XJUN icon
5630
FT Vest US Equity Enhance & Moderate Buffer ETF June
XJUN
$139M
$48K ﹤0.01%
1,242
+742
+148% +$28.5K
GRDN
5631
Guardian Pharmacy Services
GRDN
$2.44B
$48K ﹤0.01%
2,393
+2,216
+1,252% +$45.8K
CTV
5632
DELISTED
Innovid Corp.
CTV
$48K ﹤0.01%
15,477
+2,905
+23% +$6.86K
CELU icon
5633
Celularity
CELU
$20.7M
$47K ﹤0.01%
22,500
CHAT icon
5634
Roundhill Generative AI & Technology ETF
CHAT
$1.95B
$47K ﹤0.01%
1,167
CHWY icon
5635
PUT
Chewy
CHWY
$9.12B
$47K ﹤0.01%
+1,400
New +$43.5K
CTEC icon
5636
Global X ClimateTech ETF
CTEC
$26.3M
$47K ﹤0.01%
1,383
+35
+3% +$1.28K
HYI
5637
Western Asset High Yield Opportunity Fund Inc
HYI
$135M
$47K ﹤0.01%
4,007
-887
-18% -$10.8K
SMLV icon
5638
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$262M
$47K ﹤0.01%
363
-11,745
-97% -$1.54M
TRUE
5639
DELISTED
TrueCar
TRUE
$47K ﹤0.01%
12,811
+3,184
+33% +$12.5K
XOS icon
5640
Xos
XOS
$29.1M
$47K ﹤0.01%
14,535
+54
+0.4% +$226
AVBP icon
5641
ArriVent BioPharma
AVBP
$1.37B
$47K ﹤0.01%
1,752
-1,714
-49% -$49.2K
MIND icon
5642
MIND Technology
MIND
$42.8M
$46K ﹤0.01%
+5,850
New +$26.3K
PGNY icon
5643
Progyny
PGNY
$2.01B
$46K ﹤0.01%
2,687
-41,798
-94% -$649K
FSCS
5644
First Trust SMID Capital Strength ETF
FSCS
$59.4M
$46K ﹤0.01%
1,309
-535
-29% -$19.5K
AMLX icon
5645
Amylyx Pharmaceuticals
AMLX
$2.42B
$45K ﹤0.01%
11,874
+24
+0.2% +$113
EFIV icon
5646
State Street SPDR S&P 500 ESG ETF
EFIV
$1.04B
$45K ﹤0.01%
791
EYPT icon
5647
EyePoint Inc
EYPT
$1.22B
$45K ﹤0.01%
6,083
-201
-3% -$1.87K
HIVE
5648
HIVE Digital Technologies
HIVE
$720M
$45K ﹤0.01%
15,704
-12,375
-44% -$46.4K
HLF icon
5649
Herbalife
HLF
$1.28B
$45K ﹤0.01%
6,670
-4,529
-40% -$33.7K
LYB icon
5650
PUT
LyondellBasell Industries
LYB
$20.6B
$45K ﹤0.01%
+600
New +$50.4K

Similar funds

Royal Bank of Canada's Q4 2024 Portfolio in Review

As of Q4 2024, Royal Bank of Canada held 7,459 positions worth $501B, up 2.2% from $490B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada's Q4 2024 filing shows 484 new, 3,145 increased, 2,823 reduced and 402 closed positions. Its largest new stake was South Bow Corp: 18,412,117 shares worth $434M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.82B.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • Royal Bank of Canada's largest Q4 2024 buy was South Bow Corp: 18,412,117 shares worth $434M.
  • Royal Bank of Canada added most to NVIDIA in Q4 2024, an estimated $1.53B increase.
  • Royal Bank of Canada's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.82B.
  • Royal Bank of Canada fully exited CATALENT, INC. in Q4 2024, selling an estimated $43.7M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $501B portfolio in Q4 2024.
  • Royal Bank of Canada opened 484 new positions and closed 402 in Q4 2024.
  • Royal Bank of Canada's portfolio value rose 2.2% quarter-over-quarter to $501B.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.